$300 vs. $80,000: Low-cost cure for hepatitis C in the works
18 April 2016R&D
Non-profit group developing an affordable hepatitis C treatment costing under US$300, substantially below standard $80,000 pricing.
Back to News & Events
R&DPharco Group
Newsroom
View all newsMore stories
Manufacturing28 July 2026
Pharco Opens New Eye Drops Line, Launches "Vision for All" Initiative
Pharco has switched on a new eye drops production line at its Amreya City site in Alexandria. Alongside it, the company is launching a broader push to get more people across Egypt and the region screened for eye disease before it does lasting damage.
Read story
Corporate15 June 2026
Pharco and Saudi German Health Sign Strategic Healthcare MOU at Africa Health ExCon 2026
Pharco and Saudi German Health Egypt & North Africa signed a strategic memorandum of understanding on June 15, 2026, on the sidelines of Africa Health ExCon 2026 in Cairo. The agreement goes beyond a standard supply arrangement: it covers pharmaceutical supply chain logistics, ongoing training for medical professionals, scientific exchange, and joint sponsorship of healthcare initiatives and medical congresses.
Read story
Corporate10 February 2026
Ashmore Backs Pharco's Expansion Into Saudi Arabia With New Manufacturing Plant
Pharco is building a pharmaceutical plant in Saudi Arabia, and Ashmore Investment Saudi Arabia is putting capital behind it. The deal, signed at the PIF Private Sector Forum, is the first investment under Ashmore's Industrial Initiative, and it hands Pharco's Saudi arm, Pharco KSA, fresh money to get the plant built.
Read story
Press & media inquiries
For interview requests, image assets, or fact-checks, please contact our communications team directly.